US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist

0.317
-0.002-0.75%

Close Aug 23 16:00 ET

0.345
+0.029+9.10%

Post 20:01 ET

11.56MMarket Cap-458P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-19.48%24.5M

-15.20%30.44M

-9.67%37.13M

4.85%46.19M

-21.07%30.43M

-10.32%35.9M

-2.25%41.1M

-3.54%44.05M

-Cash and cash equivalents

19.86%24.5M

-15.20%30.44M

-70.90%11.96M

-52.00%21.14M

-46.98%20.44M

-10.32%35.9M

-2.25%41.1M

-3.54%44.05M

-Short-term investments

----

--25.16M

--25.04M

--9.99M

----

Prepaid assets

366.32%900K

217.31%825K

204.11%1.04M

92.74%823K

-5.39%193K

-9.41%260K

-11.89%341K

-44.69%427K

Other current assets

142.64%313K

113.76%233K

135.71%165K

-21.01%94K

37.23%129K

22.47%109K

-21.35%70K

0.00%119K

Total current assets

-16.38%25.71M

-13.15%31.5M

-7.67%38.33M

5.62%47.1M

-20.85%30.75M

-10.24%36.27M

-2.37%41.51M

-4.21%44.59M

Non current assets

Net PPE

220.00%96K

--106K

--109K

--98K

--30K

----

--0

----

-Gross PPE

--124K

--118K

----

--0

----

-Accumulated depreciation

---28K

---18K

---9K

----

--0

----

Non current prepaid assets

-43.09%214K

-16.94%353K

3.81%491K

21.11%631K

-56.33%376K

-51.70%425K

-38.81%473K

--521K

Other non current assets

83.87%57K

366.67%56K

307.69%53K

269.23%48K

138.46%31K

-7.69%12K

0.00%13K

-98.44%13K

Total non current assets

-16.02%367K

17.85%515K

34.36%653K

45.51%777K

-50.00%437K

-51.06%437K

-38.17%486K

-35.97%534K

Total assets

-16.37%26.08M

-12.78%32.02M

-7.18%38.98M

6.10%47.88M

-21.49%31.18M

-11.13%36.71M

-3.02%42M

-4.77%45.13M

Liabilities

Current liabilities

Payables

75.48%5.28M

25.56%1.69M

23.50%1.42M

349.54%5.35M

330.66%3.01M

132.99%1.34M

21.88%1.15M

-48.88%1.19M

-accounts payable

75.48%5.28M

25.56%1.69M

23.50%1.42M

349.54%5.35M

330.66%3.01M

132.99%1.34M

21.88%1.15M

-48.88%1.19M

Current accrued expenses

3.85%2.81M

-61.25%813K

14.00%1.3M

175.43%1.27M

648.75%2.7M

553.58%2.1M

767.18%1.14M

-28.46%460K

Current liabilities

44.71%9.12M

-11.38%3.33M

15.32%3.67M

225.82%7.47M

316.39%6.3M

199.36%3.76M

80.83%3.18M

-38.69%2.29M

Non current liabilities

Preferred securities outside stock equity

----

--0

Total non current liabilities

--0

Total liabilities

44.71%9.12M

-11.38%3.33M

15.32%3.67M

225.82%7.47M

316.39%6.3M

199.36%3.76M

80.83%3.18M

-38.69%2.29M

Shareholders'equity

Share capital

71.43%36K

40.00%21K

-common stock

71.43%36K

40.00%21K

Retained earnings

-34.82%-138.45M

-34.27%-125.94M

-36.16%-118.52M

-37.10%-112.65M

-30.38%-102.69M

-23.85%-93.8M

-18.97%-87.04M

-17.68%-82.17M

Paid-in capital

21.82%155.38M

21.99%154.59M

22.21%153.79M

22.44%153.03M

9.06%127.56M

9.47%126.72M

9.72%125.84M

10.16%124.98M

Gains losses not affecting retained earnings

-800.00%-7K

---2K

--4K

---5K

--1K

----

--0

----

Total stockholders'equity

-31.84%16.96M

-12.94%28.69M

-9.03%35.31M

-5.67%40.41M

-34.87%24.88M

-17.73%32.95M

-6.57%38.82M

-1.87%42.84M

Total equity

-31.84%16.96M

-12.94%28.69M

-9.03%35.31M

-5.67%40.41M

-34.87%24.88M

-17.73%32.95M

-6.57%38.82M

-1.87%42.84M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-19.48%24.5M	-15.20%30.44M	-9.67%37.13M	-9.67%37.13M	4.85%46.19M	-21.07%30.43M	-10.32%35.9M	-2.25%41.1M	-2.25%41.1M	-3.54%44.05M
-Cash and cash equivalents	19.86%24.5M	-15.20%30.44M	-70.90%11.96M	-70.90%11.96M	-52.00%21.14M	-46.98%20.44M	-10.32%35.9M	-2.25%41.1M	-2.25%41.1M	-3.54%44.05M
-Short-term investments	----	----	--25.16M	--25.16M	--25.04M	--9.99M	----	----	----	----
Prepaid assets	366.32%900K	217.31%825K	204.11%1.04M	204.11%1.04M	92.74%823K	-5.39%193K	-9.41%260K	-11.89%341K	-11.89%341K	-44.69%427K
Other current assets	142.64%313K	113.76%233K	135.71%165K	135.71%165K	-21.01%94K	37.23%129K	22.47%109K	-21.35%70K	-21.35%70K	0.00%119K
Total current assets	-16.38%25.71M	-13.15%31.5M	-7.67%38.33M	-7.67%38.33M	5.62%47.1M	-20.85%30.75M	-10.24%36.27M	-2.37%41.51M	-2.37%41.51M	-4.21%44.59M
Non current assets
Net PPE	220.00%96K	--106K	--109K	--109K	--98K	--30K	----	--0	--0	----
-Gross PPE	--124K	--124K	--118K	--118K	----	----	----	--0	--0	----
-Accumulated depreciation	---28K	---18K	---9K	---9K	----	----	----	--0	--0	----
Non current prepaid assets	-43.09%214K	-16.94%353K	3.81%491K	3.81%491K	21.11%631K	-56.33%376K	-51.70%425K	-38.81%473K	-38.81%473K	--521K
Other non current assets	83.87%57K	366.67%56K	307.69%53K	307.69%53K	269.23%48K	138.46%31K	-7.69%12K	0.00%13K	0.00%13K	-98.44%13K
Total non current assets	-16.02%367K	17.85%515K	34.36%653K	34.36%653K	45.51%777K	-50.00%437K	-51.06%437K	-38.17%486K	-38.17%486K	-35.97%534K
Total assets	-16.37%26.08M	-12.78%32.02M	-7.18%38.98M	-7.18%38.98M	6.10%47.88M	-21.49%31.18M	-11.13%36.71M	-3.02%42M	-3.02%42M	-4.77%45.13M
Liabilities
Current liabilities
Payables	75.48%5.28M	25.56%1.69M	23.50%1.42M	23.50%1.42M	349.54%5.35M	330.66%3.01M	132.99%1.34M	21.88%1.15M	21.88%1.15M	-48.88%1.19M
-accounts payable	75.48%5.28M	25.56%1.69M	23.50%1.42M	23.50%1.42M	349.54%5.35M	330.66%3.01M	132.99%1.34M	21.88%1.15M	21.88%1.15M	-48.88%1.19M
Current accrued expenses	3.85%2.81M	-61.25%813K	14.00%1.3M	14.00%1.3M	175.43%1.27M	648.75%2.7M	553.58%2.1M	767.18%1.14M	767.18%1.14M	-28.46%460K
Current liabilities	44.71%9.12M	-11.38%3.33M	15.32%3.67M	15.32%3.67M	225.82%7.47M	316.39%6.3M	199.36%3.76M	80.83%3.18M	80.83%3.18M	-38.69%2.29M
Non current liabilities
Preferred securities outside stock equity	----	----	----	----	----	----	----	----	----	--0
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	44.71%9.12M	-11.38%3.33M	15.32%3.67M	15.32%3.67M	225.82%7.47M	316.39%6.3M	199.36%3.76M	80.83%3.18M	80.83%3.18M	-38.69%2.29M
Shareholders'equity
Share capital	71.43%36K	71.43%36K	71.43%36K	71.43%36K	71.43%36K	40.00%21K	40.00%21K	40.00%21K	40.00%21K	40.00%21K
-common stock	71.43%36K	71.43%36K	71.43%36K	71.43%36K	71.43%36K	40.00%21K	40.00%21K	40.00%21K	40.00%21K	40.00%21K
Retained earnings	-34.82%-138.45M	-34.27%-125.94M	-36.16%-118.52M	-36.16%-118.52M	-37.10%-112.65M	-30.38%-102.69M	-23.85%-93.8M	-18.97%-87.04M	-18.97%-87.04M	-17.68%-82.17M
Paid-in capital	21.82%155.38M	21.99%154.59M	22.21%153.79M	22.21%153.79M	22.44%153.03M	9.06%127.56M	9.47%126.72M	9.72%125.84M	9.72%125.84M	10.16%124.98M
Gains losses not affecting retained earnings	-800.00%-7K	---2K	--4K	--4K	---5K	--1K	----	--0	--0	----
Total stockholders'equity	-31.84%16.96M	-12.94%28.69M	-9.03%35.31M	-9.03%35.31M	-5.67%40.41M	-34.87%24.88M	-17.73%32.95M	-6.57%38.82M	-6.57%38.82M	-1.87%42.84M
Total equity	-31.84%16.96M	-12.94%28.69M	-9.03%35.31M	-9.03%35.31M	-5.67%40.41M	-34.87%24.88M	-17.73%32.95M	-6.57%38.82M	-6.57%38.82M	-1.87%42.84M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall